Literature DB >> 19281842

Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1.

Lianqin Zhang1, Scot R Kimball, Leonard S Jefferson, Jeffrey S Shenberger.   

Abstract

Oxidants are well recognized for their capacity to reduce the phosphorylation of the mammalian target of rapamycin (mTOR) substrates, eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) and p70 S6 kinase 1 (S6K1), thereby hindering mRNA translation at the level of initiation. mTOR functions to regulate mRNA translation by forming the signaling complex mTORC1 (mTOR, raptor, GbetaL). Insulin signaling to mTORC1 is dependent upon phosphorylation of Akt/PKB and the inhibition of the tuberous sclerosis complex (TSC1/2), thereby enhancing the phosphorylation of 4E-BP1 and S6K1. In this study we report the effect of H(2)O(2) on insulin-stimulated mTORC1 activity and assembly using A549 and bovine aortic smooth muscle cells. We show that insulin stimulated the phosphorylation of TSC2 leading to a reduction in raptor-mTOR binding and in the quantity of proline-rich Akt substrate 40 (PRAS40) precipitating with mTOR. Insulin also increased 4E-BP1 coprecipitating with mTOR and the phosphorylation of the mTORC1 substrates 4E-BP1 and S6K1. H(2)O(2), on the other hand, opposed the effects of insulin by increasing raptor-mTOR binding and the ratio of PRAS40/raptor derived from the mTOR immunoprecipitates in both cell types. These effects occurred in conjunction with a reduction in 4E-BP1 phosphorylation and the 4E-BP1/raptor ratio. siRNA-mediated knockdown of PRAS40 in A549 cells partially reversed the effect of H(2)O(2) on 4E-BP1 phosphorylation but not on S6K1. These findings are consistent with PRAS40 functioning as a negative regulator of insulin-stimulated mTORC1 activity during oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281842      PMCID: PMC2677139          DOI: 10.1016/j.freeradbiomed.2009.03.001

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  44 in total

1.  Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Pauline Bonner; Rosa Bernardi; David Neal Franz; David Witte; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling.

Authors:  Greg M Findlay; Lijun Yan; Julia Procter; Virginie Mieulet; Richard F Lamb
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

3.  Roles of mitogen-activated protein kinase signal-integrating kinases 1 and 2 in oxidant-mediated eIF4E phosphorylation.

Authors:  Jeffrey S Shenberger; Lianqin Zhang; Mariah K Hughlock; Takeshi Ueda; Rie Watanabe-Fukunaga; Rikiro Fukunaga
Journal:  Int J Biochem Cell Biol       Date:  2007-05-10       Impact factor: 5.085

Review 4.  Signalling to translation: how signal transduction pathways control the protein synthetic machinery.

Authors:  Christopher G Proud
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

5.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

Authors:  Yasemin Sancak; Carson C Thoreen; Timothy R Peterson; Robert A Lindquist; Seong A Kang; Eric Spooner; Steven A Carr; David M Sabatini
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

6.  The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.

Authors:  Rebecca L Hurley; Kristin A Anderson; Jeanne M Franzone; Bruce E Kemp; Anthony R Means; Lee A Witters
Journal:  J Biol Chem       Date:  2005-06-24       Impact factor: 5.157

7.  Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/Akt-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells.

Authors:  Lingjie Guan; Kyung Song; Marybeth A Pysz; Kathryn J Curry; A Asli Hizli; David Danielpour; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

8.  PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.

Authors:  Lifu Wang; Thurl E Harris; Richard A Roth; John C Lawrence
Journal:  J Biol Chem       Date:  2007-05-17       Impact factor: 5.157

9.  The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.

Authors:  Noriko Oshiro; Rinako Takahashi; Ken-ichi Yoshino; Keiko Tanimura; Akio Nakashima; Satoshi Eguchi; Takafumi Miyamoto; Kenta Hara; Kenji Takehana; Joseph Avruch; Ushio Kikkawa; Kazuyoshi Yonezawa
Journal:  J Biol Chem       Date:  2007-05-21       Impact factor: 5.157

10.  PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.

Authors:  Bruno D Fonseca; Ewan M Smith; Vivian H-Y Lee; Carol MacKintosh; Christopher G Proud
Journal:  J Biol Chem       Date:  2007-06-29       Impact factor: 5.157

View more
  25 in total

1.  Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death.

Authors:  Long Chen; Baoshan Xu; Lei Liu; Yan Luo; Hongyu Zhou; Wenxing Chen; Tao Shen; Xiuzhen Han; Christopher D Kontos; Shile Huang
Journal:  Free Radic Biol Med       Date:  2010-12-30       Impact factor: 7.376

Review 2.  Redox control of skeletal muscle atrophy.

Authors:  Scott K Powers; Aaron B Morton; Bumsoo Ahn; Ashley J Smuder
Journal:  Free Radic Biol Med       Date:  2016-02-18       Impact factor: 7.376

3.  Elastase induces lung epithelial cell autophagy through placental growth factor: a new insight of emphysema pathogenesis.

Authors:  Hsin-Han Hou; Shih-Lung Cheng; Kuei-Pin Chung; Mark Yen-Ping Kuo; Cheng-Chang Yeh; Bei-En Chang; Hsuan-Hsuan Lu; Hao-Chien Wang; Chong-Jen Yu
Journal:  Autophagy       Date:  2014-06-25       Impact factor: 16.016

4.  Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesis.

Authors:  Abid A Kazi; Anne M Pruznak; Robert A Frost; Charles H Lang
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

5.  Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting.

Authors:  Hawley E Kunz; Jessica M Dorschner; Taylor E Berent; Thomas Meyer; Xuewei Wang; Aminah Jatoi; Rajiv Kumar; Ian R Lanza
Journal:  J Biol Chem       Date:  2020-10-01       Impact factor: 5.157

6.  Influence of Nrf2 activators on subcellular skeletal muscle protein and DNA synthesis rates after 6 weeks of milk protein feeding in older adults.

Authors:  Adam R Konopka; Jaime L Laurin; Robert V Musci; Christopher A Wolff; Justin J Reid; Laurie M Biela; Qian Zhang; Fredrick F Peelor; Christopher L Melby; Karyn L Hamilton; Benjamin F Miller
Journal:  Geroscience       Date:  2017-03-10       Impact factor: 7.713

7.  Alcohol-induced IGF-I resistance is ameliorated in mice deficient for mitochondrial branched-chain aminotransferase.

Authors:  Charles H Lang; Christopher J Lynch; Thomas C Vary
Journal:  J Nutr       Date:  2010-03-17       Impact factor: 4.798

Review 8.  Mechanistic links between oxidative stress and disuse muscle atrophy.

Authors:  Scott K Powers; Ashley J Smuder; David S Criswell
Journal:  Antioxid Redox Signal       Date:  2011-06-17       Impact factor: 8.401

Review 9.  Oxidative stress and disuse muscle atrophy: cause or consequence?

Authors:  Scott K Powers; Ashley J Smuder; Andrew R Judge
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-05       Impact factor: 4.294

10.  Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes.

Authors:  Shin-Ichi Oka; Tsuyoshi Hirata; Wataru Suzuki; Daichi Naito; Yanbin Chen; Adave Chin; Hiroaki Yaginuma; Toshiro Saito; Narayani Nagarajan; Peiyong Zhai; Santosh Bhat; Kevin Schesing; Dan Shao; Yoko Hirabayashi; Junji Yodoi; Sebastiano Sciarretta; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.